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Objectives
To measure correlations between the DAS, DAS28, Sim-
plified Disease Activity Index [SDAI], and Clinical Disease
Activity Index [CDAI]) and ACR responses; to determine
validity of these measures in polyarticular-course juvenile
idiopathic arthritis (polyJIA).
Methods
Retrospective analysis of 2 etanercept trials. Disease activ-
ity was calculated at baseline, 3 mo, and 6 mo. Data were
analyzed independent of treatment arm. Visits were clas-
sified by highest level of pediatric ACR response. EULAR
response levels were based on DAS/DAS28 values. Corre-
lation coefficients were calculated between the above
measures. Areas under the receiver operating characteristic
curve assessed discriminative characteristics of each con-
tinuous measure to the pediatric ACR response measures.
Results
Mean DAS, DAS28, CDAI, and SDAI were 3.7, 4.7, 30.8,
and 36.4 respectively at baseline, corresponding to high
disease activity levels for the DAS, CDAI and SDAI, and
moderate for the DAS28. At 3 mo, mean values corre-
sponded to low disease activity for the DAS/DAS28, and
moderate for the CDAI/SDAI. At 6 mo, mean scores corre-
sponded to low disease activity for the DAS/DAS28/CDAI,
and moderate for the SDAI. Good EULAR response was
seen at 3 and 6 mo. Correlation between the continuous
outcome measures and the pediatric core set components
was moderate to very good, with the closest correlation
observed between the active joint count (kappa = 0.62–
0.97).
Conclusion
Good correlation was seen between the DAS, DAS28,
CDAI, and SDAI and the ACR pediatric measures of
response, supporting value for prospective validation in
polyJIA.
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